Founded in 2004 in Hong Kong, RimAsia Capital Partners focuses on investing in the mid-market sector within Asia. They prefer to invest in businesses with strong prospects that could benefit from their capital and expertise. Their notable investment portfolio includes companies like Caladrius Biosciences and Actions Semiconductor. Since their founding, they have made two investments, with their most recent investment being in April 2009 when Caladrius Biosciences raised $11M. RimAsia Capital Partners has had two notable exits. They primarily invest in rounds with 3-4 participants and typically target deals in the range of $10-50 million. Some of their key sponsors in investment rounds include Shanghai Industrial Holdings, New Enterprise Associates, and Intel Capital.